This study is testing whether an investigational treatment called depemokimab, added to regular COPD treatment, can help reduce COPD flare-ups and is safe for people with moderate to severe COPD.
Participar es tu decisión. Puedes abandonar el estudio en cualquier momento.
Condición
Chronic Obstructive Pulmonary Disease (COPD)
Para quién es
40–80 years
Visitas
Not reported
Tiempo requerido
24 months
Formato del estudio
Randomized, double-blind, placebo-controlled study.
Tratamiento del estudio
Proporcionado, sin costo
Compensación
Not reported
Tu privacidad
Mantenida privada y segura
Elegibilidad
Si tienes un diagnóstico de esta condición, podrías ser elegible para participar. Esta es una guía sencilla sobre quién puede unirse.
Estas son pautas generales. El equipo del estudio confirma quién puede unirse tras una verificación breve y amistosa.
El desafío actual
People with moderate to severe COPD often keep having flare-ups even while using their regular inhalers, and each flare-up can further damage the lungs and lower quality of life.
Lo que los investigadores esperan aprender
Whether adding Depemokimab, an investigational add-on medicine, to standard inhaler treatment can reduce how often flare-ups happen in adults with COPD who have signs of a specific type of airway inflammation.
Cómo puede ayudar este tratamiento
If effective, Depemokimab may lower the number and severity of flare-ups over time, on top of the inhalers a participant is already using.
Checks confirm you meet the study's health criteria
Starting point measurements are recorded before treatment begins
You continue your usual inhalers, with the study medicine or placebo added
A final check-in after treatment ends
1.Learn about the study
Read through what's involved and ask any questions
2.Screening visit
The study team checks your health history and current COPD status
3.Find out if you qualify
Based on your seizure (COPD, not seizures) based on your lung function and exacerbation history
4.Start treatment
Begin receiving the study medicine alongside your usual inhalers
5.Regular check-ins
The study team monitors your symptoms and any flare-ups
6.Study completion
A final visit wraps up your participation
For check-ups and study medicine administration
The study medicine is an add-on, not a replacement
Let the study team know if your symptoms worsen
Brief check-ins about how you're feeling
El equipo del estudio te explicará cada posible antes de que decidas. Tendrás tiempo para hacer preguntas.
Not reported
No. You do not need insurance to take part, and study-related care is provided at no cost to you.
Often yes, but it depends on the study. Share your full medication list with the study team and they will guide you.
Yes. Taking part is your choice, and you can stop at any time for any reason, without affecting your regular care.
You can call or email the study team any time. There is no such thing as a question that is too small.
Yes. Your information is kept private and secure, and only approved people can see your study data.
Toca cualquier palabra para ver su significado en lenguaje sencillo.
Chronic Obstructive Pulmonary Disease (COPD) elegibilidad
Answer a few simple questions about your COPD, breathing treatments, and health history to see if you may be a potential match for this research study.